Karen Shoos Lipton serves as Executive at AVANT IMMUNOTHERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Karen Shoos Lipton has executed 13 insider transactions totaling $445.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 15, 2017 involved receiving (via award) 10,000 shares valued at $0.
Karen Shoos Lipton currently holds 41,833 shares of AVANT IMMUNOTHERAPEUTICS INC (AVAN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Shoos Lipton has been a net seller of AVAN stock. They have purchased $11.2K and sold $434.3K worth of shares.
Karen Shoos Lipton's most recent insider trade was on Jun 15, 2017, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 10, 2015 | CLDX | $0 | Award | 6,500 | $N/A | Discretionary |
| Jun 4, 2014 | CLDX | $0 | Award | 2,000 | $N/A | Discretionary |
| Dec 6, 2013 | CLDX | $144.7K | Option Exercise | 17,728 | $8.16 | Discretionary |
| Dec 6, 2013 | CLDX | $434.3K | Sale | 17,728 | $24.50 | Discretionary |
| Jun 19, 2013 | CLDX | $0 | Award | 2,000 | $N/A | Discretionary |
| Jun 20, 2012 | CLDX | $0 | Award | 2,000 | $N/A | Discretionary |
| Jun 22, 2011 | CLDX | $0 | Award | 2,000 | $N/A | Discretionary |
| Sep 22, 2010 | CLDX | $0 | Award | 2,000 | $N/A | Discretionary |
| Sep 16, 2010 | CLDX | $11.2K | Purchase | 3,000 | $3.74 | Discretionary |
| Dec 23, 2009 | CLDX | $0 | Award | 2,000 | $N/A | Discretionary |
| May 15, 2006 | AVAN | $4.9K | Option Exercise | 4,000 | $1.23 | Discretionary |